Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata

Overview of attention for article published in Drug Design, Development and Therapy, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

Il ritlecitinib, commercializzato con il nome di Litfulo, è un farmaco utilizzato per il trattamento dell'alopecia areata grave (perdita di capelli).

Ritlecitinib, vândut sub marca Litfulo, este un medicament utilizat pentru tratamentul alopeciei areate severe (căderea părului).

Ritlecitinib, sold under the brand name Litfulo, is a medication used for the treatment of severe alopecia areata (hair loss).

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.